Status: Recruiting
CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
The objective of CIRCULATE trial is to improve care of patients after colon tumor surgery, based on an innovative marker: circulating tumor DNA.
Participants needed: 1,980
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire DijonUpdated: Jul 10, 2026Locations: 1
Eligibility criteria
Signed written informed consent obtained prior to any study specific procedures [+19]
T4b tumors [+8]